Merck’s Keytruda extends survival in bile duct most cancers sufferers

(Reuters) – Merck & Co Inc stated on Wednesday its blockbuster most cancers drug Keytruda together with a chemotherapy confirmed important enchancment in general survival in sufferers with a complicated sort of bile duct most cancers.

(Reporting by Raghav Mahobe in Bengaluru; Enhancing by Arun Koyyur)

Previous post The Pre-Owned Non-public Jet Market Is Hovering within the US Because of Savvy Fliers
Next post Commerce again for a large receiver